Entreprise · 21/12/19981 min de lecture
Oral Dosage Form New Animal Drugs; Oxytetracycline Tablet/Bolus
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc. The NADA provides for use of oxytetracycline boluses for control and treatment of bacterial enteritis and bacterial pneumonia in beef and dairy calves.